BORTEZOMIB TEVA 1 MG

देश: इसराइल

भाषा: अंग्रेज़ी

स्रोत: Ministry of Health

सक्रिय संघटक:

BORTEZOMIB

थमां उपलब्ध:

ABIC MARKETING LTD, ISRAEL

ए.टी.सी कोड:

L01XX32

फार्मास्यूटिकल फॉर्म:

POWDER FOR SOLUTION FOR INJECTION

रचना:

BORTEZOMIB 1 MG

प्रशासन का मार्ग:

I.V

प्रिस्क्रिप्शन प्रकार:

Required

द्वारा बनाया गया:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

चिकित्सीय क्षेत्र:

BORTEZOMIB

चिकित्सीय संकेत:

Bortezomib Teva is indicated for the treatment of patients with multiple myeloma. Bortezomib Teva is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. Bortezomib Teva in combination with rituximab, cyclophosphamide, doxorubicin and prednisone is indicated for the treatment of adult patients with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation

प्राधिकरण की तारीख:

2017-07-04